Sustained complete molecular remission after imatinib discontinuation due to severe aplastic anemia

Leuk Res. 2009 Apr;33(4):589-92. doi: 10.1016/j.leukres.2008.08.011. Epub 2008 Sep 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Analgesics, Non-Narcotic / therapeutic use
  • Anemia, Aplastic / chemically induced*
  • Anti-Bacterial Agents / therapeutic use
  • Antifungal Agents / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Cyclosporine / therapeutic use
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Mycoses / drug therapy
  • Piperazines / adverse effects*
  • Pyrimidines / adverse effects*
  • Remission Induction
  • Respiratory Tract Infections / drug therapy

Substances

  • Analgesics, Non-Narcotic
  • Anti-Bacterial Agents
  • Antifungal Agents
  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Cyclosporine
  • Imatinib Mesylate